|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$82,119,756 |
|
|
Indirect Value
|
$12,961,771,173 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,043,890,929 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 28 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GHDX |
Genomic Health Inc |
N/A |
|
2006-09-08 |
4 |
B |
$14.12 |
$898,488 |
I/I |
63,408 |
233,732 |
0.01 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-05-10 |
4 |
B |
$29.86 |
$2,051,783 |
I/I |
68,681 |
234,540 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2005-05-04 |
4 |
B |
$4.79 |
$30,199 |
I/I |
6,305 |
234,861 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-05-11 |
4 |
B |
$30.22 |
$805,567 |
I/I |
26,660 |
235,167 |
2.25 |
- |
|
INCY |
Incyte Corp |
Director |
|
2010-09-23 |
4 |
S |
$14.86 |
$84,424 |
I/I |
(5,681) |
237,497 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2010-05-25 |
4 |
B |
$11.95 |
$1,793 |
I/I |
150 |
238,716 |
2.17 |
- |
|
INCY |
Incyte Corp |
Director |
|
2010-09-23 |
4 |
S |
$14.86 |
$85,033 |
I/I |
(5,722) |
239,258 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-05-14 |
4 |
B |
$31.53 |
$7,153,896 |
I/I |
212,438 |
239,821 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2010-04-30 |
4 |
B |
$12.76 |
$151,919 |
I/I |
11,901 |
241,295 |
1.5 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2010-06-07 |
4 |
B |
$11.87 |
$36,899 |
I/I |
3,105 |
241,821 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-05-15 |
4 |
B |
$33.11 |
$4,772,474 |
I/I |
140,000 |
242,888 |
2.25 |
- |
|
INCY |
Incyte Corp |
Director |
|
2010-09-22 |
4 |
S |
$14.71 |
$105,631 |
I/I |
(7,180) |
243,178 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-05-16 |
4 |
B |
$34.46 |
$813,925 |
I/I |
23,621 |
243,405 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2005-03-23 |
4 |
B |
$4.96 |
$353,505 |
I/I |
71,278 |
244,728 |
2.25 |
- |
|
INCY |
Incyte Corp |
Director |
|
2010-09-22 |
4 |
S |
$14.71 |
$106,410 |
I/I |
(7,233) |
244,980 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2005-03-28 |
4 |
B |
$4.90 |
$3,964 |
I/I |
809 |
245,537 |
2.17 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-07-23 |
4 |
S |
$14.86 |
$146,198 |
I/I |
(9,839) |
246,499 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-05-21 |
4 |
B |
$32.04 |
$4,826,973 |
I/I |
150,000 |
246,683 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-05-22 |
4 |
B |
$32.94 |
$573,401 |
I/I |
17,406 |
247,063 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2010-05-10 |
4 |
S |
$12.70 |
$666,930 |
I/I |
(52,508) |
248,829 |
0 |
- |
|
INCY |
Incyte Corp |
10% Owner |
|
2003-09-19 |
4 |
B |
$5.04 |
$542,276 |
I/I |
107,650 |
249,700 |
1.5 |
- |
|
INCY |
Incyte Corp |
Director |
|
2010-09-21 |
4 |
S |
$14.94 |
$288,265 |
I/I |
(19,291) |
250,358 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2010-09-21 |
4 |
S |
$14.94 |
$290,387 |
I/I |
(19,433) |
252,213 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2005-03-29 |
4 |
B |
$4.81 |
$41,039 |
I/I |
8,420 |
253,957 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2011-08-10 |
4 |
B |
$16.12 |
$98,403 |
I/I |
5,934 |
254,763 |
1.5 |
- |
|
1397 Records found
|
|
Page 28 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|